Aurer I - Search Results

1

Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non interventional study of the Croatian Cooperative Group for Hematologic Diseases.

Bašić-Kinda S, Mišura Jakobac K, Sinčić-Petričević J, Deak D, Vodanović M, Jakić-Bubalo M, Mitrović Z, Grubešić A, Dreta B, Županić Krmek D, Coha B, Radić-Krišto D, Aurer I. Bašić-Kinda S, et al. Among authors: aurer i. Croat Med J. 2021 Oct 31;62(5):455-463. doi: 10.3325/cmj.2021.62.455-63. Croat Med J. 2021. PMID: 34730885 Free PMC article.

2

Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin's disease (Croatian experience).

Radman I, Basić N, Labar B, Kovacević J, Aurer I, Bogdanić V, Zupancić-Salek S, Nemet D, Jakić-Razumović J, Mrsić M, Santek F, Grgić-Markulin L, Boban D. Radman I, et al. Among authors: aurer i. Ann Oncol. 2002 Oct;13(10):1650-5. doi: 10.1093/annonc/mdf271. Ann Oncol. 2002. PMID: 12377656 Free article.

3

Combination of ifosfamide, methotrexate, and etoposide (IMVP) as a salvage therapy for relapsed and refractory aggressive non-Hodgkin lymphoma: retrospective study.

Aurer I, Duraković N, Radman I, Nemet D, Zupancić-Salek S, Kovacević-Metelko J, Bogdanić V, Sertić D, Mrsić M, Mikulić M, Labar B. Aurer I, et al. Croat Med J. 2002 Oct;43(5):550-4. Croat Med J. 2002. PMID: 12402394 Free article.

4

Surgical resection in the treatment of primary gastrointestinal non-Hodgkin's lymphoma: retrospective study.

Radman I, Kovacević-Metelko J, Aurer I, Nemet D, Zupancić-Salek S, Bogdanić V, Sertić D, Mrsić M, Pulanić R, Gasparović V, Labar B. Radman I, et al. Among authors: aurer i. Croat Med J. 2002 Oct;43(5):555-60. Croat Med J. 2002. PMID: 12402395 Free article.

5

[Rituximab in the treatment of indolent non-Hodgkin's lymphoma].

Aurer I, Mitrović Z, Radman I, Kovacević-Metelko J, Nemet D, Serventi-Seiwerth R, Stern-Padovan R, Jakic-Razumović J, Nola M, Zupancić-Salek S, Sertić D, Labar B. Aurer I, et al. Lijec Vjesn. 2004 Nov-Dec;126(11-12):307-11. Lijec Vjesn. 2004. PMID: 16082888 Clinical Trial. Croatian.

6

[Rituximab in the treatment of B-cell non-Hodgkin lymphoma].

Mitrović Z, Aurer I. Mitrović Z, et al. Among authors: aurer i. Lijec Vjesn. 2006 Jan-Feb;128(1-2):36-42. Lijec Vjesn. 2006. PMID: 16640226 Review. Croatian.

7

[Treatment of hairy cell leukemia with cladribine].

Aurer I, Mitrović Z, Kovacević-Metelko J, Radman I, Basić-Kinda S, Gjadrov-Kuvezdić K, Jakić-Razumović J, Dubravcić K, Ries S, Nola M, Zupancic-Salek S, Labar B. Aurer I, et al. Lijec Vjesn. 2007 Mar-Apr;129(3-4):80-3. Lijec Vjesn. 2007. PMID: 17557550 Croatian.

8

FCgammaRIIIA and FCgammaRIIA polymorphisms are not associated with response to rituximab and CHOP in patients with diffuse large B-cell lymphoma.

Mitroviç Z, Aurer I, Radman I, Ajdukoviç R, Sertiç J, Labar B. Mitroviç Z, et al. Among authors: aurer i. Haematologica. 2007 Jul;92(7):998-9. doi: 10.3324/haematol.10327. Haematologica. 2007. PMID: 17606457 Free article.

9

[Primary central nervous system lymphoma--a single center experience].

Mitrović Z, Radman I, Aurer I, Petranović D, Santek F, Labar B. Mitrović Z, et al. Among authors: aurer i. Lijec Vjesn. 2007 Dec;129(12):391-5. Lijec Vjesn. 2007. PMID: 18383741 Croatian.

10

Treatment of relapsed or refractory aggressive non-hodgkin lymphoma with two ifosfamide-based regimens, IMVP and ICE.

Aurer I, Mitrović Z, Nemet D, Radman I, Sertić D, Serventi-Seiwerth R, Stern-Padovan R, Santek F, Nola M, Mrsić M, Labar B. Aurer I, et al. J Chemother. 2008 Oct;20(5):640-4. doi: 10.1179/joc.2008.20.5.640. J Chemother. 2008. PMID: 19048695 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page